tiprankstipranks
Advertisement
Advertisement

RANI Stock Latest News

Rani Therapeutics initiated with a Buy at Chardan
The FlyRani Therapeutics initiated with a Buy at Chardan
9d ago
RANI
Rani Therapeutics reports Q2 EPS (4c), consensus (5c)
PremiumThe Fly
Rani Therapeutics reports Q2 EPS (4c), consensus (5c)
11d ago
RANI
Rani Therapeutics appoints Michelle Gilson to board
PremiumCompany Announcements
Rani Therapeutics appoints Michelle Gilson to board
23d ago
8K
RANI
Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up
PremiumWeekend Updates
Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up
1M ago
PNC
URI
Rani Therapeutics reports initial data from RT-114 study
PremiumThe Fly
Rani Therapeutics reports initial data from RT-114 study
1M ago
RANI
Rani Therapeutics Maintained at Buy as Partnerships Highlight Underappreciated Pipeline; $11 Price Target Reaffirmed
PremiumRatingsRani Therapeutics Maintained at Buy as Partnerships Highlight Underappreciated Pipeline; $11 Price Target Reaffirmed
1M ago
RANI
Rani Therapeutics announces research, development collaboration with PegBio
Premium
The Fly
Rani Therapeutics announces research, development collaboration with PegBio
2M ago
RANI
Rani Therapeutics management to meet virtually with Lake Street
Premium
The Fly
Rani Therapeutics management to meet virtually with Lake Street
2M ago
RANI
Rani Therapeutics Appoints New Chief Financial Officer
PremiumCompany Announcements
Rani Therapeutics Appoints New Chief Financial Officer
2M ago
8K
RANI
Rani Therapeutics appoints Nicholas Maestas as CFO
PremiumThe Fly
Rani Therapeutics appoints Nicholas Maestas as CFO
2M ago
RANI
TPST
Rani Therapeutics Rated Buy as Analyst Highlights RT-114 Progress, Chugai Partnership and Cash Runway; $11 Price Target Reiterated
PremiumRatings
Rani Therapeutics Rated Buy as Analyst Highlights RT-114 Progress, Chugai Partnership and Cash Runway; $11 Price Target Reiterated
3M ago
RANI
Rani Therapeutics Shareholders Back Board and Auditor at Meeting
PremiumCompany Announcements
Rani Therapeutics Shareholders Back Board and Auditor at Meeting
3M ago
8K
RANI
Rani Therapeutics Announces $20 Million Equity Financing
PremiumCompany AnnouncementsRani Therapeutics Announces $20 Million Equity Financing
3M ago
8K
RANI
Nasdaq Delisting Risk Looms as Rani Therapeutics Fails to Meet $1 Minimum Bid Price
Premium
Company Announcements
Nasdaq Delisting Risk Looms as Rani Therapeutics Fails to Meet $1 Minimum Bid Price
3M ago
RANI
Rani Therapeutics Faces Nasdaq Bid Price Noncompliance Notice
Premium
Company Announcements
Rani Therapeutics Faces Nasdaq Bid Price Noncompliance Notice
3M ago
8K
RANI
Rani Therapeutics CFO Svai Sanford to step down
PremiumThe Fly
Rani Therapeutics CFO Svai Sanford to step down
3M ago
RANI
Rani Therapeutics reports Q1 EPS (4c), consensus (5c)
PremiumThe Fly
Rani Therapeutics reports Q1 EPS (4c), consensus (5c)
3M ago
RANI
Edward Nash Reiterates Buy on Rani Therapeutics, Maintains Unchanged $5 Price Target Amid Encouraging RT-114 and Oral Biologics Platform Outlook
PremiumRatings
Edward Nash Reiterates Buy on Rani Therapeutics, Maintains Unchanged $5 Price Target Amid Encouraging RT-114 and Oral Biologics Platform Outlook
4M ago
RANI
Rani Therapeutics price target lowered to $5 from $9 at Canaccord
PremiumThe Fly
Rani Therapeutics price target lowered to $5 from $9 at Canaccord
5M ago
RANI
Rani Therapeutics reports Q4 EPS (7c), consensus (7c)
PremiumThe FlyRani Therapeutics reports Q4 EPS (7c), consensus (7c)
5M ago
RANI
Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings
Premium
The Fly
Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings
5M ago
RANI
RANI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RANI Upcoming Earnings Report: What to Expect?
5M ago
RANI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >